Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Prophylactic Human Vaccines Market, 2022: Pediatric Prophylactic Vaccines, and Adult Prophylactic Vaccines - Global Strategic Business Report 2016 - Research and Markets

Research and Markets
Posted on: 24 Aug 16

Research and Markets has announced the addition of the "Prophylactic Human Vaccines - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Prophylactic Human Vaccines in US$ Million by the following Product Segments: Pediatric Prophylactic Vaccines, and Adult Prophylactic Vaccines.

The report profiles 63 companies including many key and niche players such as

  • ALK
  • Abelló A/S (Denmark)
  • Altimmune, Inc. (US)
  • Bavarian Nordic A/S (Denmark)
  • BiondVax Pharmaceuticals Ltd. (Israel)
  • Bharat Biotech International Limited (India)
  • GlaxoSmithKline Plc. (UK)
  • Hualan Biological Engineering Inc. (China)
  • Janssen Pharmaceuticals, Inc. (US)
  • MedImmune (US)
  • Merck & Co., Inc. (US)
  • Pfizer Inc. (US)
  • Sanofi Pasteur SA (France)
  • Serum Institute of India Pvt. Ltd. (India)
  • Shanghai BravoBio Co., Ltd. (China)
  • Seqirus (UK)
  • SK Chemicals Co., Ltd. (Korea)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Zydus Cadila (India)

Key Topics Covered:

1. Market Overview & Outlook

2. Market Trends & Issues

3. Competitive Landscape

4. Product Overview

5. Clinical Trials In The Vaccines Market

6. Product Launches/Approvals

7. Recent Industry Activity

8. Focus On Select Players

9. Global Market Perspective

Total Companies Profiled: 63 (including Divisions/Subsidiaries 72)

  • The United States (22)
  • Canada (1)
  • Japan (5)
  • Europe (14)
  • - France (3)
  • - Germany (2)
  • - The United Kingdom (2)
  • - Spain (1)
  • - Rest of Europe (6)
  • Asia-Pacific (Excluding Japan) (28)
  • Latin America (1)
  • Middle East (1)

For more information about this report visit

Related Topics: Vaccines

View source version on

Business Wire

Last updated on: 24/08/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.